KB

Kevin Bitterman

Partner at Atlas Venture

Cambridge, Massachusetts

Overview

Work Experience

AV

Atlas Venture

  • Partner

    2017 - Current

CM

Chroma Medicine

  • Board Chair

    2020

RT

Remix Therapeutics

  • Board of Directors

    2019

MO

Mariana Oncology

  • Board of Directors

    2021

KT

Kinaset Therapeutics

  • Board of Directors

    2020

DM

Disc Medicine

  • Board Of Directors

    2017

IS

Isabella Stewart Gardner Museum

  • Advisory Board Member

    2017

AT

Akero Therapeutics

  • Board of Directors

    2018 - 2021

NP

Navitor Pharmaceuticals

  • Board of Directors

    2017 - 2020

Education

Investments

Disc Medicine

Series A

Total Funding: $440M

Remix Therapeutics

Seed

Total Funding: $210M

Mariana Oncology

Series A

Total Funding: $250M

Curie Therapeutics

Series A

Total Funding: $75M

Relevant Websites